Business Context and Reporting Period
Healthcare Triangle, Inc. (HCTI), a Delaware corporation, filed this Form 8-K on June 26, 2024. The report addresses a notification received from the Nasdaq Stock Market LLC regarding the Company's failure to meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Key Financial Metrics
This filing is a current report regarding listing status and does not contain financial statements. Consequently, data on revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The material event reported is the Company's stock price closing below $1.00 per share for the last 30 consecutive business days. This triggers a non-compliance status under Nasdaq Listing Rule 5550(a)(2). The Company's stock remains listed on the Nasdaq Capital Market under the symbol "HCTI" pending the outcome of the compliance period.
Guidance, Outlook, and Risks
- Compliance Timeline: The Company has an initial 180-day compliance period ending December 23, 2024, to regain compliance.
- Compliance Criteria: To regain compliance, the bid price must close at $1.00 or more for a minimum of ten consecutive business days before the deadline.
- Secondary Compliance Period: If the initial period is unsuccessful, the Company may be eligible for an additional 180-day period, contingent on meeting market value of publicly held shares and other initial listing standards. This may require a reverse stock split.
- Risks: There is no assurance the Company will regain compliance. Failure to do so may result in delisting. The Company is currently evaluating options to cure the deficiency.
- Forward-Looking Statements: The filing includes standard disclaimers that future results may differ materially from expectations due to various risks and uncertainties.
Investor Verification Checklist
- Verify the current trading price of HCTI to assess the likelihood of meeting the $1.00 bid price threshold within the 180-day window.
- Monitor for announcements regarding a potential reverse stock split if the Company fails to regain compliance by December 23, 2024.
- Review the Company's most recent 10-K or 10-Q filings for financial health indicators, as this 8-K contains no financial data.
- Check for any subsequent 8-K filings regarding the Company's appeal of a potential delisting determination or the status of its compliance efforts.